These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22129109)

  • 1. Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine.
    Huang YL; Pang VF; Lin CM; Tsai YC; Chia MY; Deng MC; Chang CY; Jeng CR
    Vet Res; 2011 Dec; 42(1):115. PubMed ID: 22129109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine circovirus type 2 decreases the infection and replication of attenuated classical swine fever virus in porcine alveolar macrophages.
    Huang YL; Pang VF; Deng MC; Chang CY; Jeng CR
    Res Vet Sci; 2014 Feb; 96(1):187-95. PubMed ID: 24370262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of porcine circovirus associated diseases on live attenuated classical swine fever vaccine in field farm applications.
    Chen JY; Wu CM; Liao CM; Chen KC; You CC; Wang YW; Huang C; Chien MS
    Vaccine; 2019 Oct; 37(43):6535-6542. PubMed ID: 31500966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain).
    Lim SI; Jeoung HY; Kim B; Song JY; Kim J; Kim HY; Cho IS; Woo GH; Lee JB; An DJ
    Vet Microbiol; 2016 Sep; 193():36-41. PubMed ID: 27599928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective CSFV-PCV2 bivalent vaccine effectively protects against classical swine fever virus and porcine circovirus type 2 dual challenge and prevents horizontal transmission.
    Chen JY; Wu CM; Chia MY; Huang C; Chien MS
    Vet Res; 2023 Jul; 54(1):57. PubMed ID: 37434231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
    Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
    Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
    Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
    Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
    Park C; Oh Y; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions.
    Opriessnig T; Xiao CT; Halbur PG; Gerber PF; Matzinger SR; Meng XJ
    Vaccine; 2017 Jan; 35(2):248-254. PubMed ID: 27919634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted Expression of the Cap Gene of Porcine Circovirus Type 2 in Classical Swine Fever Virus C-Strain: Potential of C-Strain Used as a Vaccine Vector.
    Zhang L; Li Y; Xie L; Wang X; Gao X; Sun Y; Qiu HJ
    Viruses; 2017 Oct; 9(10):. PubMed ID: 29035292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of chronic and persistent classical swine fever infections under field conditions and their impact on vaccine efficacy.
    Coronado L; Bohórquez JA; Muñoz-González S; Perez LJ; Rosell R; Fonseca O; Delgado L; Perera CL; Frías MT; Ganges L
    BMC Vet Res; 2019 Jul; 15(1):247. PubMed ID: 31307464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
    Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
    Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C; Jeong J; Choi K; Chae C
    Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a live attenuated vaccine in classical swine fever virus postnatally persistently infected pigs.
    Muñoz-González S; Perez-Simó M; Muñoz M; Bohorquez JA; Rosell R; Summerfield A; Domingo M; Ruggli N; Ganges L
    Vet Res; 2015 Jul; 46(1):78. PubMed ID: 26159607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Maternal Antibody Transfer on Antibody Dynamics and Control of Porcine Circovirus Type 2 Infection in Offspring.
    Dvorak CMT; Payne BJ; Seate JL; Murtaugh MP
    Viral Immunol; 2018; 31(1):40-46. PubMed ID: 28817375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
    Oh Y; Seo HW; Park C; Chae C
    Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.